Paul Knight
Stock Analyst at Keybanc
(2.36)
# 2,647
Out of 5,105 analysts
140
Total ratings
45.69%
Success rate
-1.73%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Upgrades: Overweight | $750 | $572.28 | +31.05% | 7 | Dec 8, 2025 | |
| WST West Pharmaceutical Services | Maintains: Overweight | $325 → $350 | $267.56 | +30.81% | 12 | Oct 24, 2025 | |
| XGN Exagen | Maintains: Overweight | $12 → $15 | $7.11 | +110.97% | 7 | Oct 14, 2025 | |
| LFCR Lifecore Biomedical | Initiates: Sector Weight | n/a | $7.79 | - | 1 | Sep 4, 2025 | |
| ATR AptarGroup | Initiates: Overweight | $220 | $121.47 | +81.11% | 1 | Sep 4, 2025 | |
| CYRX Cryoport | Upgrades: Overweight | $15 | $9.40 | +59.57% | 9 | Aug 6, 2025 | |
| EHC Encompass Health | Maintains: Overweight | $122 → $135 | $107.00 | +26.17% | 1 | May 27, 2025 | |
| HBIO Harvard Bioscience | Downgrades: Sector Weight | n/a | $0.74 | - | 5 | Apr 9, 2025 | |
| TECH Bio-Techne | Downgrades: Sector Weight | n/a | $58.51 | - | 9 | Apr 9, 2025 | |
| WAT Waters | Upgrades: Overweight | $460 | $385.33 | +19.38% | 5 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $1.45 | - | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $8 | $3.64 | +119.78% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $132 → $145 | $100.49 | +44.29% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $420 | $204.97 | +104.91% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $213 → $230 | $101.18 | +127.32% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $33 | $24.39 | +35.30% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $36 | $38.63 | -6.81% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $310 | $226.33 | +36.97% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $220 | $157.39 | +39.78% | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $37 | $20.82 | +77.71% | 5 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $3.60 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $4.71 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $139.68 | - | 8 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $35.30 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $11.17 | +258.10% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $193.03 | +55.42% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $222.26 | +12.48% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $126.88 | +247.57% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $148.43 | +59.00% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $82.08 | +20.61% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $11.75 | +368.09% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $42.84 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $77.77 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $134.87 | - | 5 | Oct 23, 2017 |
Thermo Fisher Scientific
Dec 8, 2025
Upgrades: Overweight
Price Target: $750
Current: $572.28
Upside: +31.05%
West Pharmaceutical Services
Oct 24, 2025
Maintains: Overweight
Price Target: $325 → $350
Current: $267.56
Upside: +30.81%
Exagen
Oct 14, 2025
Maintains: Overweight
Price Target: $12 → $15
Current: $7.11
Upside: +110.97%
Lifecore Biomedical
Sep 4, 2025
Initiates: Sector Weight
Price Target: n/a
Current: $7.79
Upside: -
AptarGroup
Sep 4, 2025
Initiates: Overweight
Price Target: $220
Current: $121.47
Upside: +81.11%
Cryoport
Aug 6, 2025
Upgrades: Overweight
Price Target: $15
Current: $9.40
Upside: +59.57%
Encompass Health
May 27, 2025
Maintains: Overweight
Price Target: $122 → $135
Current: $107.00
Upside: +26.17%
Harvard Bioscience
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.74
Upside: -
Bio-Techne
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $58.51
Upside: -
Waters
Mar 31, 2025
Upgrades: Overweight
Price Target: $460
Current: $385.33
Upside: +19.38%
Feb 27, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $1.45
Upside: -
Feb 12, 2025
Initiates: Overweight
Price Target: $8
Current: $3.64
Upside: +119.78%
Feb 3, 2025
Maintains: Overweight
Price Target: $132 → $145
Current: $100.49
Upside: +44.29%
Jan 23, 2025
Maintains: Overweight
Price Target: $400 → $420
Current: $204.97
Upside: +104.91%
Jan 23, 2025
Maintains: Overweight
Price Target: $213 → $230
Current: $101.18
Upside: +127.32%
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $24.39
Upside: +35.30%
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $38.63
Upside: -6.81%
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $226.33
Upside: +36.97%
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $157.39
Upside: +39.78%
Aug 30, 2023
Maintains: Overweight
Price Target: $35 → $37
Current: $20.82
Upside: +77.71%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $3.60
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $4.71
Upside: -
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $139.68
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $35.30
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $11.17
Upside: +258.10%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $193.03
Upside: +55.42%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $222.26
Upside: +12.48%
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $126.88
Upside: +247.57%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $148.43
Upside: +59.00%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $82.08
Upside: +20.61%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $11.75
Upside: +368.09%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $42.84
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $77.77
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $134.87
Upside: -